Cargando…
The gestational diabetes future diabetes prevention study (GODDESS): A partially randomised feasibility controlled trial
OBJECTIVES: To assess the feasibility of an ante- and post-natal lifestyle intervention for women with gestational diabetes mellitus (GDM) to reduce type 2 diabetes risk. DESIGN: A partially randomised patient preference feasibility trial. SETTING: Diabetes antenatal clinics in two inner-London hosp...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803154/ https://www.ncbi.nlm.nih.gov/pubmed/36584120 http://dx.doi.org/10.1371/journal.pone.0273992 |
_version_ | 1784861817765363712 |
---|---|
author | Parsons, Judith Forde, Rita Brackenridge, Anna Hunt, Katharine F. Ismail, Khalida Murrells, Trevor Reid, Anna Rogers, Helen Rogers, Rebecca Forbes, Angus |
author_facet | Parsons, Judith Forde, Rita Brackenridge, Anna Hunt, Katharine F. Ismail, Khalida Murrells, Trevor Reid, Anna Rogers, Helen Rogers, Rebecca Forbes, Angus |
author_sort | Parsons, Judith |
collection | PubMed |
description | OBJECTIVES: To assess the feasibility of an ante- and post-natal lifestyle intervention for women with gestational diabetes mellitus (GDM) to reduce type 2 diabetes risk. DESIGN: A partially randomised patient preference feasibility trial. SETTING: Diabetes antenatal clinics in two inner-London hospitals, UK. PARTICIPANTS: Pregnant women ≥18 years with a GDM diagnosis and pre-pregnancy body mass index of ≥25kg/m(2). INTERVENTION: Participants in the intervention group were offered four motivational interview-based sessions (two antenatally and two postnatally, at 3 and 6 months postpartum), a WhatsApp support group, a FitBit and electronic self-help resources. OUTCOME MEASURES: Recruitment; retention; intervention dose received; data completion; adaptions; proportion achieving ≥5% weight loss; weight change, blood glucose; blood pressure; diet, physical activity, breastfeeding and depression. Clinical outcomes were measured at baseline and 6 months postpartum. RESULTS: 50 participants were recruited from 155 eligible women (32% recruitment rate). Thirty-four were recruited to the intervention group (23 following randomisation (RI-group) and 11 based on preference (PI-group)); and 16 to the control group (13 randomised (RC-group) and 3 preference (PC-group)). Attrition was 44% (n = 22/50). Forty-six percent (n = 6) of the intervention group (25% (n = 2) of the RI-group and 80% (n = 4) of the PI-group) achieved ≥5% weight loss compared to 8% (n = 1) in the control group (95% confidence interval (CI) -0.69 to 0.07). Mean weight change was -2.1kg±9.0 in the intervention group (0kg±5.4 in the RI-group and -5.4kg±13.0 in the PI-group) compared to +4.4kg±4.9 in the control group (RC +4.4kg ±5.3 and PC +4.7kg ±3.1, 95% CI -12.4 to 0.2). CONCLUSIONS: Recruitment was feasible, but strategies to improve retention are needed. The findings suggest the intervention can support women with GDM to lose weight. The observed weight loss was primarily in women who preferred the intervention. Therefore, future trials may need to adopt a preference design and consider factors associated with preference. TRIAL REGISTRATION: Trial registration: ISRCTN52675820 https://www.isrctn.com/ISRCTN52675820?q=ISRCTN52675820&filters=&sort=&offset=1&totalResults=1&page=1&pageSize=10&searchType=basic-search. |
format | Online Article Text |
id | pubmed-9803154 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-98031542022-12-31 The gestational diabetes future diabetes prevention study (GODDESS): A partially randomised feasibility controlled trial Parsons, Judith Forde, Rita Brackenridge, Anna Hunt, Katharine F. Ismail, Khalida Murrells, Trevor Reid, Anna Rogers, Helen Rogers, Rebecca Forbes, Angus PLoS One Research Article OBJECTIVES: To assess the feasibility of an ante- and post-natal lifestyle intervention for women with gestational diabetes mellitus (GDM) to reduce type 2 diabetes risk. DESIGN: A partially randomised patient preference feasibility trial. SETTING: Diabetes antenatal clinics in two inner-London hospitals, UK. PARTICIPANTS: Pregnant women ≥18 years with a GDM diagnosis and pre-pregnancy body mass index of ≥25kg/m(2). INTERVENTION: Participants in the intervention group were offered four motivational interview-based sessions (two antenatally and two postnatally, at 3 and 6 months postpartum), a WhatsApp support group, a FitBit and electronic self-help resources. OUTCOME MEASURES: Recruitment; retention; intervention dose received; data completion; adaptions; proportion achieving ≥5% weight loss; weight change, blood glucose; blood pressure; diet, physical activity, breastfeeding and depression. Clinical outcomes were measured at baseline and 6 months postpartum. RESULTS: 50 participants were recruited from 155 eligible women (32% recruitment rate). Thirty-four were recruited to the intervention group (23 following randomisation (RI-group) and 11 based on preference (PI-group)); and 16 to the control group (13 randomised (RC-group) and 3 preference (PC-group)). Attrition was 44% (n = 22/50). Forty-six percent (n = 6) of the intervention group (25% (n = 2) of the RI-group and 80% (n = 4) of the PI-group) achieved ≥5% weight loss compared to 8% (n = 1) in the control group (95% confidence interval (CI) -0.69 to 0.07). Mean weight change was -2.1kg±9.0 in the intervention group (0kg±5.4 in the RI-group and -5.4kg±13.0 in the PI-group) compared to +4.4kg±4.9 in the control group (RC +4.4kg ±5.3 and PC +4.7kg ±3.1, 95% CI -12.4 to 0.2). CONCLUSIONS: Recruitment was feasible, but strategies to improve retention are needed. The findings suggest the intervention can support women with GDM to lose weight. The observed weight loss was primarily in women who preferred the intervention. Therefore, future trials may need to adopt a preference design and consider factors associated with preference. TRIAL REGISTRATION: Trial registration: ISRCTN52675820 https://www.isrctn.com/ISRCTN52675820?q=ISRCTN52675820&filters=&sort=&offset=1&totalResults=1&page=1&pageSize=10&searchType=basic-search. Public Library of Science 2022-12-30 /pmc/articles/PMC9803154/ /pubmed/36584120 http://dx.doi.org/10.1371/journal.pone.0273992 Text en © 2022 Parsons et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Parsons, Judith Forde, Rita Brackenridge, Anna Hunt, Katharine F. Ismail, Khalida Murrells, Trevor Reid, Anna Rogers, Helen Rogers, Rebecca Forbes, Angus The gestational diabetes future diabetes prevention study (GODDESS): A partially randomised feasibility controlled trial |
title | The gestational diabetes future diabetes prevention study (GODDESS): A partially randomised feasibility controlled trial |
title_full | The gestational diabetes future diabetes prevention study (GODDESS): A partially randomised feasibility controlled trial |
title_fullStr | The gestational diabetes future diabetes prevention study (GODDESS): A partially randomised feasibility controlled trial |
title_full_unstemmed | The gestational diabetes future diabetes prevention study (GODDESS): A partially randomised feasibility controlled trial |
title_short | The gestational diabetes future diabetes prevention study (GODDESS): A partially randomised feasibility controlled trial |
title_sort | gestational diabetes future diabetes prevention study (goddess): a partially randomised feasibility controlled trial |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803154/ https://www.ncbi.nlm.nih.gov/pubmed/36584120 http://dx.doi.org/10.1371/journal.pone.0273992 |
work_keys_str_mv | AT parsonsjudith thegestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial AT forderita thegestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial AT brackenridgeanna thegestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial AT huntkatharinef thegestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial AT ismailkhalida thegestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial AT murrellstrevor thegestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial AT reidanna thegestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial AT rogershelen thegestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial AT rogersrebecca thegestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial AT forbesangus thegestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial AT parsonsjudith gestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial AT forderita gestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial AT brackenridgeanna gestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial AT huntkatharinef gestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial AT ismailkhalida gestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial AT murrellstrevor gestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial AT reidanna gestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial AT rogershelen gestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial AT rogersrebecca gestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial AT forbesangus gestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial |